UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Corpay
CPAY
$25.9B
| $31.4M | 0.03% |
211,161
+1,890
| +0.9% | +$272K |
|
552
Lexicon Pharmaceuticals
LXRX
$1.11B
| $31.3M | 0.03% |
4,919,820
+1,565,652
| +47% | +$12.6M |
|
553
Charter Communications
CHTR
$18.3B
| $31.3M | 0.03% |
188,020
-1,168
| -0.6% | -$185K |
|
554
Pembina Pipeline
PBA
$28.1B
| $31.2M | 0.03% |
854,387
-156,888
| -16% | -$5.95M |
|
555
Cintas
CTAS
$81.5B
| $31.2M | 0.03% |
1,590,976
-9,440
| -0.6% | -$171K |
|
556
RenaissanceRe
RNR
$13.4B
| $31.2M | 0.03% |
320,848
+17,898
| +6% | +$1.78M |
|
557
TripAdvisor
TRIP
$1.67B
| $31.1M | 0.03% |
416,461
+41,720
| +11% | +$3.26M |
|
|
FDO
558
DELISTED
FAMILY DOLLAR STORES
FDO
| $31.1M | 0.03% |
392,323
+22,129
| +6% | +$1.74M |
|
559
FMC
FMC
$1.32B
| $30.8M | 0.03% |
623,303
-13,869
| -2% | -$676K |
|
|
DNB
560
DELISTED
Dun & Bradstreet
DNB
| $30.7M | 0.03% |
253,424
-18,788
| -7% | -$2.27M |
|
561
Puma Biotechnology
PBYI
$397M
| $30.5M | 0.03% |
161,300
+5,700
| +4% | +$1.26M |
|
562
Mohawk Industries
MHK
$9.25B
| $30.5M | 0.03% |
196,331
-6,430
| -3% | -$924K |
|
|
TRW
563
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $30.4M | 0.03% |
295,890
-9,159
| -3% | -$935K |
|
|
MXIM
564
DELISTED
Maxim Integrated Products
MXIM
| $30.4M | 0.03% |
953,505
-98,034
| -9% | -$2.88M |
|
|
ESV
565
DELISTED
Ensco Rowan plc
ESV
| $30.4M | 0.03% |
253,400
-41,002
| -14% | -$5.88M |
|
566
Masco
MAS
$15.2B
| $30.3M | 0.03% |
1,366,974
-35,729
| -3% | -$738K |
|
|
DRE
567
DELISTED
Duke Realty Corp.
DRE
| $29.9M | 0.03% |
1,481,081
-259,153
| -15% | -$4.91M |
|
568
Regency Centers
REG
$14.5B
| $29.7M | 0.03% |
466,109
-16,534
| -3% | -$998K |
|
569
Pinnacle West Capital
PNW
$12.3B
| $29.7M | 0.03% |
434,536
-2,828
| -0.6% | -$176K |
|
|
TGNA
570
DELISTED
TEGNA Inc
TGNA
| $29.6M | 0.03% |
1,772,801
+548,416
| +45% | +$8.83M |
|
|
SGEN
571
DELISTED
Seagen Inc. Common Stock
SGEN
| $29.2M | 0.03% |
907,697
+160,700
| +22% | +$5.6M |
|
|
FUEL
572
DELISTED
Rocket Fuel Inc.
FUEL
| $29M | 0.03% |
1,797,464
-153,462
| -8% | -$2.54M |
|
573
HDFC Bank
HDB
$123B
| $28.9M | 0.03% |
2,278,540
-1,036,608
| -31% | -$13.1M |
|
|
CHL
574
DELISTED
China Mobile Limited
CHL
| $28.8M | 0.03% |
489,798
+1,300
| +0.3% | +$77.9K |
|
|
UPL
575
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $28.6M | 0.03% |
2,171,414
-87,380
| -4% | -$1.76M |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.